X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1533) 1533
Book Review (515) 515
Publication (95) 95
Book Chapter (25) 25
Conference Proceeding (4) 4
Magazine Article (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
glucocorticoid-induced osteoporosis (1338) 1338
index medicus (1206) 1206
humans (1021) 1021
osteoporosis (655) 655
female (617) 617
male (505) 505
endocrinology & metabolism (399) 399
bone-mineral density (359) 359
middle aged (354) 354
osteoporosis - chemically induced (339) 339
glucocorticoids - adverse effects (310) 310
bone density - drug effects (292) 292
postmenopausal women (290) 290
adult (276) 276
rheumatology (270) 270
aged (268) 268
corticosteroids (264) 264
bone density (261) 261
animals (257) 257
osteoporosis - drug therapy (248) 248
risk factors (242) 242
prevention (235) 235
fractures (228) 228
corticosteroid-induced osteoporosis (201) 201
bone density conservation agents - therapeutic use (195) 195
mineral density (189) 189
osteoporosis - prevention & control (188) 188
therapy (186) 186
bone mineral density (175) 175
orthopedics (164) 164
medicine & public health (163) 163
glucocorticoids (157) 157
diphosphonates - therapeutic use (148) 148
medicine, general & internal (147) 147
rheumatoid-arthritis (144) 144
double-blind (143) 143
bisphosphonates (139) 139
bones (134) 134
alendronate (133) 133
pharmacology & pharmacy (128) 128
density (121) 121
osteoporosis - etiology (116) 116
calcium (115) 115
abridged index medicus (112) 112
bone (111) 111
women (111) 111
management (109) 109
absorptiometry, photon (108) 108
analysis (108) 108
adolescent (106) 106
parathyroid-hormone (106) 106
vitamin d (106) 106
steroids (105) 105
health aspects (102) 102
risk (101) 101
adrenal cortex hormones - adverse effects (99) 99
care and treatment (98) 98
osteoporosis - physiopathology (97) 97
bone and bones - metabolism (95) 95
endocrinology (95) 95
vertebral fracture (95) 95
postmenopausal osteoporosis (94) 94
bone density - physiology (93) 93
osteoporosis - diagnosis (92) 92
child (89) 89
drug therapy (89) 89
glucocorticoids - therapeutic use (89) 89
aged, 80 and over (88) 88
vitamin-d (86) 86
fracture (85) 85
hip fracture (85) 85
rats (85) 85
fractures, bone - etiology (84) 84
osteoblasts (84) 84
osteoporosis - therapy (84) 84
research (84) 84
bone and bones - drug effects (83) 83
disease (83) 83
dexamethasone (82) 82
teriparatide (82) 82
bone loss (81) 81
osteoporosis - complications (80) 80
vertebral fractures (79) 79
treatment outcome (78) 78
apoptosis (77) 77
medicine, research & experimental (77) 77
mice (76) 76
rheumatoid arthritis (75) 75
time factors (74) 74
parathyroid hormone (73) 73
mechanisms (72) 72
fractures, bone - prevention & control (70) 70
randomized controlled-trial (70) 70
fracture risk (69) 69
osteoporosis - metabolism (69) 69
hormone replacement therapy (68) 68
complications and side effects (66) 66
transplantation (66) 66
glucocorticoids - administration & dosage (65) 65
steroid-induced osteoporosis (65) 65
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1379) 1379
Japanese (84) 84
German (34) 34
French (18) 18
Chinese (9) 9
Spanish (9) 9
Russian (7) 7
Polish (5) 5
Czech (4) 4
Portuguese (3) 3
Korean (2) 2
Indonesian (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


SEMINARS IN NUCLEAR MEDICINE, ISSN 0001-2998, 11/2014, Volume 44, Issue 6, pp. 439 - 450
Osteoporotic fractures are common and result in extensive morbidity and mortality. It is possible to decrease the risk of fracture in postmenopausal, male, and... 
CONTINUING OUTCOMES RELEVANT | VITAMIN-D SUPPLEMENTATION | BONE-MINERAL DENSITY | VERTEBRAL FRACTURE RISK | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | CATHEPSIN-K INHIBITOR | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | HEALTHY POSTMENOPAUSAL WOMEN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GROWTH-FACTOR-I
Journal Article
Osteoporosis International, ISSN 0937-941X, 10/2008, Volume 19, Issue 10, pp. 1395 - 1408
Assessment and intervention thresholds are developed and proposed in men aged over 50 years and postmenopausal women for the UK based on fracture probability... 
Fracture probability | FRAX | Medicine & Public Health | Gynecology | Orthopedics | Assessment thresholds | Rheumatology | BMD | Clinical risk factors | Intervention thresholds | Osteoporotic fracture | Endocrinology | FRAX (R) | COST-EFFECTIVENESS | BONE-MINERAL DENSITY | fracture probability | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | ELDERLY-WOMEN | osteoporotic fracture | ALENDRONATE | intervention thresholds | POSTMENOPAUSAL OSTEOPOROSIS | ECONOMIC-EVALUATION | VERTEBRAL FRACTURE RISK | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | assessment thresholds | clinical risk factors | RISEDRONATE | Osteoporosis, Postmenopausal - epidemiology | Risk Assessment - methods | Age Factors | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Fractures, Bone - epidemiology | Male | Osteoporosis - drug therapy | Patient Selection | Fractures, Bone - etiology | Aged, 80 and over | Female | Osteoporosis - epidemiology | Bone Density | Decision Support Techniques | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - economics | Algorithms | Cost-Benefit Analysis | Osteoporosis - complications | Femur Neck - physiopathology | Aged | United Kingdom - epidemiology | Fractures, Bone - prevention & control | Osteoporosis | Bones | Bone density | Fractures | Health risk assessment | Index Medicus | Postmenopausal | methods | 80 and over | epidemiology | Great Britain | Endokrinologi och diabetes | Bone Density Conservation Agents | Physiology | Endocrinology and Diabetes | drug therapy | complications | Risk Assessment | Fysiologi | Femur Neck | prevention & control | etiology | economics | physiopathology | Bone | therapeutic use
Journal Article
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, ISSN 0889-857X, 02/2007, Volume 33, Issue 1, pp. 149 - 149
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2006, Volume 101, Issue 1, pp. 177 - 185
Journal Article
CLINICS IN GERIATRIC MEDICINE, ISSN 0749-0690, 08/2005, Volume 21, Issue 3, pp. 603 - 603
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 09/2015, Volume 173, Issue 3, pp. R131 - R151
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 07/2019, Volume 31, Issue 4, pp. 388 - 393
PURPOSE OF REVIEWSteroid-induced osteoporosis or glucocorticoid-induced osteoporosis (GIOP) is a common form of secondary osteoporosis and is a cause of... 
RHEUMATOID-ARTHRITIS | RISK | bone | RHEUMATOLOGY | INCIDENT VERTEBRAL FRACTURES | fracture | BONE LOSS | THERAPY | review | DOUBLE-BLIND | glucocorticoid-induced osteoporosis | randomized clinical trials | RISEDRONATE | ALENDRONATE USE | ADVERSE EVENTS | ONSET | Complications and side effects | Osteoporosis | Development and progression | Corticosteroids | Drug therapy | Risk factors
Journal Article
Chest, ISSN 0012-3692, 2011, Volume 139, Issue 3, pp. 648 - 657
COPD and osteoporosis are strongly associated because of common risk factors such as age, smoking, and inactivity. In addition, COPD-related systemic... 
Pulmonary/Respiratory | OBSTRUCTIVE PULMONARY-DISEASE | MINERAL DENSITY | POSTMENOPAUSAL OSTEOPOROSIS | RANDOMIZED-CONTROLLED-TRIALS | VERTEBRAL FRACTURES | RESPIRATORY SYSTEM | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | OLDER MEN | VITAMIN-D DEFICIENCY | CONSENSUS DOCUMENT | EVIDENCE-BASED GUIDELINES | Prevalence | Vitamin D Deficiency - complications | Humans | Calcium - administration & dosage | Vitamin D Deficiency - drug therapy | Fractures, Bone - epidemiology | Adrenal Cortex Hormones - therapeutic use | Osteoporosis - metabolism | Bone and Bones - metabolism | Vitamin D - administration & dosage | Pulmonary Disease, Chronic Obstructive - metabolism | Osteoporosis - epidemiology | Calcium - pharmacology | Osteoporosis - prevention & control | Risk Factors | Adrenal Cortex Hormones - pharmacology | Bone Density Conservation Agents - therapeutic use | Bone Density Conservation Agents - administration & dosage | Pulmonary Disease, Chronic Obstructive - complications | Bone Density Conservation Agents - pharmacology | Adrenal Cortex Hormones - adverse effects | Bone Density - drug effects | Calcium - therapeutic use | Vitamin D - therapeutic use | Vitamin D Deficiency - metabolism | Dietary Supplements | Pulmonary Disease, Chronic Obstructive - drug therapy | Prevention | Osteoporosis | Care and treatment | Lung diseases, Obstructive | Physiological aspects | Bones | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2013, Volume 28, Issue 6, pp. 1355 - 1368
Data on treatment of glucocorticoid-induced osteoporosis (GIO) in men are scarce. We performed a randomized, open-label trial in men who have taken... 
GLUCOCORTICOID‐INDUCED OSTEOPOROSIS | BONE MINERAL DENSITY | BONE MICROSTRUCTURE | VERTEBRAL FRACTURE | FINITE ELEMENT ANALYSIS | MALE OSTEOPOROSIS | HIGH RESOLUTION QUANTITATIVE COMPUTED TOMOGRAPHY | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | QUANTITATIVE COMPUTED-TOMOGRAPHY | CORTICOSTEROID-INDUCED OSTEOPOROSIS | FRACTURE RISK | ALENDRONATE | TRABECULAR BONE | THERAPY | ENDOCRINOLOGY & METABOLISM | PARATHYROID-HORMONE | POSTMENOPAUSAL WOMEN | VERTEBRAL MICROSTRUCTURE | FINITE-ELEMENT-ANALYSIS | Glucocorticoids - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Osteoporosis - drug therapy | Spinal Fractures - metabolism | Osteoporosis - metabolism | Osteoporosis - diagnostic imaging | Aged, 80 and over | Adult | Female | Risedronate Sodium | Etidronic Acid - analogs & derivatives | Glucocorticoids - adverse effects | Etidronic Acid - administration & dosage | Lumbar Vertebrae - metabolism | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Lumbar Vertebrae - diagnostic imaging | Teriparatide - administration & dosage | Europe | Bone Density Conservation Agents - administration & dosage | Spinal Fractures - diagnostic imaging | Radiography | Bone Density - drug effects | Aged | Osteoporosis | Corticosteroids | Comparative analysis | Steroids | Tomography | Bone density | Index Medicus | Original
Journal Article
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2013, Volume 28, Issue 3, pp. 439 - 441
The management of osteoporosis is changing--for the better. Perhaps the most progressive recent step has been the assessment of fracture risk using clinical... 
TRIAL | WOMEN | DIAGNOSIS | MANAGEMENT | TURNOVER | BONE-MINERAL DENSITY | REDUCTION | GUIDELINES | ENDOCRINOLOGY & METABOLISM | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | NONVERTEBRAL FRACTURE RISK | Osteoporosis - drug therapy | Humans | Osteoporosis | Index Medicus | Dual energy X-ray absorptiometry | Fractures | Cardiovascular diseases | Risk assessment | Risk factors
Journal Article
Journal Article
Expert Review of Endocrinology and Metabolism, ISSN 1744-6651, 03/2019, Volume 14, Issue 2, pp. 111 - 122
Journal Article